Cosmo BIOCOSMO BIO COMPANY, LIMITED3386東証スタンダード卸売業FY ending Dec 2025, consolidated, J-GAAP

What does Cosmo BIO do with its cash?

How cash from operations was spent on investment, dividends, buybacks and more.

Operating cash flow
¥595M
Capex
¥281M
of revenue 2.6%
Free cash flow
¥314M
Returned to shareholders
¥434M
of net income: 129%
Dividend per share
¥50
Payout ratio (reported)
78.5%

Cash flow ratios

Cash conversion, investment and shareholder payments calculated from disclosed figures.

Net income¥337M
Operating cash flow¥595M
Cash conversion (operating CF ÷ operating income)
173.5%
Cash vs. profit gap
¥258M(純利益の 76.6%)
Shareholder returns
of net income 128.8% · of FCF 138.2%
Shareholder payments — dividends
of net income 103.3% · of FCF 110.8%
CapEx intensity (capex ÷ revenue)
2.6%
Investing CF relative to operating CF
7.2%

Nonpositive profit and free cash flow are omitted as ratio denominators. Amounts use the period's reported currency.

Five-year trend

Operating cash flow¥595M
FY ending Dec 2021: ¥648M¥648MFY ending Dec 2022: ¥284M¥284MFY ending Dec 2023: ¥736M¥736MFY ending Dec 2024: ¥241M¥241MFY ending Dec 2025: ¥595M¥595MFY21FY22FY23FY24FY25
Free cash flow¥314M
FY ending Dec 2021: ¥507M¥507MFY ending Dec 2022: ¥180M¥180MFY ending Dec 2023: ¥636M¥636MFY ending Dec 2024: -¥35M-¥35MFY ending Dec 2025: ¥314M¥314MFY21FY22FY23FY24FY25
Net income¥337M
FY ending Dec 2021: ¥737M¥737MFY ending Dec 2022: ¥517M¥517MFY ending Dec 2023: ¥442M¥442MFY ending Dec 2024: ¥262M¥262MFY ending Dec 2025: ¥337M¥337MFY21FY22FY23FY24FY25

How to read this

  • Operating cash flow is the cash the core business actually brought in, including changes in receivables and inventory.
  • Free cash flow = operating cash flow − capital expenditure: a gauge of cash available for other uses.
  • Large "borrowing" or "cash drawdown" flows mean the company spent more than it generated that year.

Sources

Show source documents (6)
  • EDINET (FSA Japan)

    有価証券報告書-第43期(2025/01/01-2025/12/31)

    ID S100XRR02026-03-18Open
  • EDINET (FSA Japan)

    有価証券報告書-第42期(2024/01/01-2024/12/31)

    ID S100VGUM2025-03-26Open
  • EDINET (FSA Japan)

    有価証券報告書-第41期(2023/01/01-2023/12/31)

    ID S100T53U2024-03-27Open
  • EDINET (FSA Japan)

    有価証券報告書-第40期(2022/01/01-2022/12/31)

    ID S100QFZF2023-03-24Open
  • EDINET (FSA Japan)

    有価証券報告書-第39期(令和3年1月1日-令和3年12月31日)

    ID S100NPSM2022-03-24Open
  • EDINET (FSA Japan)

    有価証券報告書-第38期(令和2年1月1日-令和2年12月31日)

    ID S100L0HC2021-03-24Open

Extracted from XBRL: 51 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.